Condition: CADASIL · CADASIL (Diagnosis) · Moya Moya Disease · Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Cerebrovascular diseases (CVDs) are one leading cause of morbidity and mortality worldwide. Despite intensive investigations, more than 30% of strokes remain of undetermined origin. Rare Cerebrovascular Diseases (rCVDs), including heritable (i.e., CADASIL, COL4A1 syndrome, Fabry disease) and acquired conditions (i.e., Sneddon syndrome, Moyamoya arteriopathy) account for a proportion of these strokes. However, rCVDs are often misdiagnosed since clinicians are not able to recognize them. Although rare, the identification of these stroke causes is important to establish appropriate management measures, including genetic counselling, and, if available, therapy. The lack of data on phenotype and clinical course of rCVDs, given the paucity of published series, makes the diagnosis and the development of therapies challenging. Furthermore, the molecular characterization of rCVDs is still lacking, despite progresses achieved in common stroke by applying high throughput approaches as multi-omics. Since the diagnosis and care of rCVDs require adequate expertise and instrumental tools, clinical and research activities are usually reserved to few specialized centers, mostly located in the North of Italy, leading patients to expensive trips for consultations. Therefore, the creation of a clinical and research network aimed at improving the diagnostic pathways of rCVDs is highly needed to improve the number of patients with rCVDs to better define the clinical phenotype and to transfer the k…
This description comes directly from the study's public registry record.
Anna Bersano, MD · + 39 02.2394 · anna.bersano@istituto-besta.it
Always discuss trial participation with your own doctor first.
| Ospedale Regionale Generale "F. Miulli", Acquaviva delle Fonti | Acquaviva delle Fonti, BA, Italy | Recruiting |
| ASST Melegnano Martesana | Melegnano, MI, Italy | Recruiting |
| Neurologia Stroke Unit dell'Asst Rhodense | Rho, Mi, Italy | Recruiting |
| Fondazione Istituto G. Giglio, Cefalù | Cefalù, PA, Italy | Recruiting |
| UO Neurologia degli Ospedali di Cesena e Forlì, Ospedale Bufalini Cesena ed Ospedale Morgagni-Pierantoni (Ausl della Romagna) | Cesena, Italy | Recruiting |
| ASST di Cremona | Cremona, Italy | Recruiting |
| Ospedale "Spaziani" di Frosinone | Frosinone, Italy | Recruiting |
| U.O. Neurologia, Ospedale Sant'Andrea, La Spezia | La Spezia, Italy | Recruiting |
| ASST Grande Ospedale Metropolitano Niguarda | Milan, Italy | Recruiting |
| Fondazione IRCCS Istituto Neurologico Carlo Besta | Milan, Italy | Recruiting |
| Ospedale Luigi Sacco, ASST Fatebenefratelli Sacco | Milan, Italy | Recruiting |
| Stroke Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano | Milan, Italy | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06935578